Monday, 19 December 2011

Quetiapine Fumarate




Quetiapine Fumarate may be available in the countries listed below.


Ingredient matches for Quetiapine Fumarate



Quetiapine

Quetiapine Fumarate (BANM, USAN) is known as Quetiapine in the US.

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 16 December 2011

Lithicarb




Lithicarb may be available in the countries listed below.


Ingredient matches for Lithicarb



Lithium

Lithium carbonate (a derivative of Lithium) is reported as an ingredient of Lithicarb in the following countries:


  • Australia

  • New Zealand

International Drug Name Search

Friday, 9 December 2011

Miraxil




Miraxil may be available in the countries listed below.


Ingredient matches for Miraxil



Proxymetacaine

Proxymetacaine hydrochloride (a derivative of Proxymetacaine) is reported as an ingredient of Miraxil in the following countries:


  • Colombia

International Drug Name Search

Thursday, 8 December 2011

Atrovent Monodosis




Atrovent Monodosis may be available in the countries listed below.


Ingredient matches for Atrovent Monodosis



Ipratropium

Ipratropium Bromide is reported as an ingredient of Atrovent Monodosis in the following countries:


  • Spain

International Drug Name Search

Thursday, 24 November 2011

Gonadotropin Deficiency Medications


Definition of Gonadotropin Deficiency: Absent or decreased gonadal function (the male testis or the female ovary) resulting from the absence of the gonadal stimulating pituitary hormones FSH (follicle stimulating hormone) and LH (luteinizing hormone). More...

Drugs associated with Gonadotropin Deficiency

The following drugs and medications are in some way related to, or used in the treatment of Gonadotropin Deficiency. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Gonadotropin Deficiency





Drug List:

Saturday, 19 November 2011

Soventol




Soventol may be available in the countries listed below.


Ingredient matches for Soventol



Bamipine

Bamipine lactate (a derivative of Bamipine) is reported as an ingredient of Soventol in the following countries:


  • Germany

  • India

  • Luxembourg

  • Poland

International Drug Name Search

Tuesday, 8 November 2011

Tuinal




In the US, Tuinal is a member of the drug class barbiturates.

Ingredient matches for Tuinal



Amobarbital

Amobarbital sodium salt (a derivative of Amobarbital) is reported as an ingredient of Tuinal in the following countries:


  • United Kingdom

Secobarbital

Secobarbital sodium salt (a derivative of Secobarbital) is reported as an ingredient of Tuinal in the following countries:


  • United Kingdom

International Drug Name Search

Monday, 7 November 2011

Polysept




Polysept may be available in the countries listed below.


Ingredient matches for Polysept



Povidone Iodine

Povidone-Iodine is reported as an ingredient of Polysept in the following countries:


  • Germany

  • Israel

International Drug Name Search

Tuesday, 1 November 2011

Hidrotiadol




Hidrotiadol may be available in the countries listed below.


Ingredient matches for Hidrotiadol



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Hidrotiadol in the following countries:


  • Dominican Republic

International Drug Name Search

Friday, 28 October 2011

Wintermin




Wintermin may be available in the countries listed below.


Ingredient matches for Wintermin



Chlorpromazine

Chlorpromazine is reported as an ingredient of Wintermin in the following countries:


  • Japan

International Drug Name Search

Monday, 24 October 2011

Gonal-f RFF Pen


See also: Generic Gonal-f, Generic Gonal-f RFF


Gonal-f RFF Pen is a brand name of follicle stimulating hormone, approved by the FDA in the following formulation(s):


GONAL-F RFF PEN (follitropin alfa/beta - injectable; subcutaneous)



  • Manufacturer: EMD SERONO

    Approval date: May 25, 2004

    Strength(s): 300 IU/0.5ML [RLD], 450 IU/0.75ML [RLD], 900 IU/1.5ML [RLD]

Has a generic version of Gonal-f RFF Pen been approved?


No. There is currently no therapeutically equivalent version of Gonal-f RFF Pen available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Gonal-f RFF Pen. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Follicle stimulating hormone and pharmaceutical compositions containing same
    Patent 5,767,067
    Issued: June 16, 1998
    Inventor(s): Arpaia; Guiseppe & Serani; Serenella & Sirna; Antonino & Villa; Stefano
    Assignee(s): Istituto di Ricerca Cesare Serono S.p.A.
    Purification of human FSH from post-menopausal urine gonadogropin using immunochromatography and reverse phase HPLC steps yelds a biologically active hormone which is free from detectable traces of LH and other urinary proteins.
    Patent expiration dates:

    • June 16, 2015
      ✓ 
      Drug substance




  • Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof
    Patent 5,767,251
    Issued: June 16, 1998
    Inventor(s): Reddy; Vermuri B. & Hsiung; Nancy & Beck; Anton K. & Bernstine; Edward George
    Assignee(s): Genzyme Corporation
    Biologically active heterodimeric human fertility hormones composed of two different subunits, each subunit being synthesized in the same cell transformed by at least one cell expression vector having heterologous DNA encoding each subunit with each subunit being controlled by a separate promoter. Preferred human fertility hormones include hCG, hLH and hFSH.
    Patent expiration dates:

    • June 16, 2015
      ✓ 
      Drug substance




  • FSH formulation
    Patent 7,446,090
    Issued: November 4, 2008
    Inventor(s): Hoffmann; James Arthur & Lu; Jirong
    Assignee(s): Ares Trading S.A.
    This invention relates to FSH or a FSH variant containing an alpha and beta subunit contained in formulations, and articles of manufacture. The invention provides advantageous new proteins and nucleic acids, multi-use pharmaceutical solutions, formulations and products of said proteins and nucleic acids where none approved for commercial use had previously existed having such extended use indications. These products are particularly useful in therapeutic regimens for increasing serum levels of FSH or a FSH variant over a period of treatment. Thus, inter alia, the invention fills the need for convenient products of FSH or from a FSH variant.
    Patent expiration dates:

    • August 23, 2019
      ✓ 
      Drug product




  • Liquid pharmaceutical formulations of FSH and LH together with a non-ionic surfactant
    Patent 7,741,268
    Issued: June 22, 2010
    Inventor(s): Samaritani; Fabrizio & Donati; Piergiorgio
    Assignee(s): Ares Trading S.A.
    The invention relates to the field of pharmaceutical formulations of follicle-stimulating hormone (FSH), luteinising hormone (LH), and mixtures of FSH and luteinising hormone (LH), and to methods of producing such formulations. The invention provides a liquid or freeze-dried formulation of FSH, or LH, or FSH and LH comprising a surfactant selected from Pluronic® F77, Pluronic F87, Pluronic F88 and Pluronic F68.
    Patent expiration dates:

    • April 2, 2024
      ✓ 
      Drug product



See also...

  • Gonal-f RFF Pen Solution Consumer Information (Wolters Kluwer)
  • Gonal-f RFF Pen Consumer Information (Cerner Multum)
  • Follitropin Alfa Powder Consumer Information (Wolters Kluwer)
  • Follitropin Alfa Solution Consumer Information (Wolters Kluwer)
  • Follitropin Beta Consumer Information (Wolters Kluwer)
  • Follicle stimulating hormone Consumer Information (Cerner Multum)
  • Follitropin alfa Subcutaneous Advanced Consumer Information (Micromedex)
  • Follitropin beta Subcutaneous Advanced Consumer Information (Micromedex)

Friday, 21 October 2011

Indoramine




Indoramine may be available in the countries listed below.


Ingredient matches for Indoramine



Indoramin

Indoramine (DCF) is also known as Indoramin (Rec.INN)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 13 October 2011

Monoginal




Monoginal may be available in the countries listed below.


Ingredient matches for Monoginal



Isosorbide Mononitrate

Isosorbide Mononitrate is reported as an ingredient of Monoginal in the following countries:


  • Greece

International Drug Name Search

Friday, 7 October 2011

Pantaxin




Pantaxin may be available in the countries listed below.


Ingredient matches for Pantaxin



Cefotaxime

Cefotaxime sodium salt (a derivative of Cefotaxime) is reported as an ingredient of Pantaxin in the following countries:


  • Philippines

International Drug Name Search

Sunday, 2 October 2011

Simvastatine




Simvastatine may be available in the countries listed below.


Ingredient matches for Simvastatine



Simvastatin

Simvastatine (DCF) is known as Simvastatin in the US.

International Drug Name Search

Glossary

DCFDénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 1 October 2011

Omeprazole-EG




Omeprazole-EG may be available in the countries listed below.


Ingredient matches for Omeprazole-EG



Omeprazole

Omeprazole is reported as an ingredient of Omeprazole-EG in the following countries:


  • Luxembourg

International Drug Name Search

Saturday, 24 September 2011

Pancreatin




In some countries, this medicine may only be approved for veterinary use.


In the US, Pancreatin (pancreatin systemic) is a member of the drug class digestive enzymes and is used to treat Chronic Pancreatitis, Cystic Fibrosis, Pancreatic Cancer and Pancreatitis.

US matches:

  • Pancreatin

  • Pancreatin 4X

Scheme

BAN

CAS registry number (Chemical Abstracts Service)

0008049-47-6

Therapeutic Category

Pancreatic enzyme

Chemical Name

Preparation of mammalian pancreas containing enzymes having protease, lipase and amylase activity

Foreign Names

  • Pancreatinum (Latin)
  • Pankreatin (German)

Generic Names

  • Pancreatin (OS: BAN)
  • Pancreas polvere (PH: Ph. Eur. 5)
  • Pancreas powder (PH: Ph. Eur. 5)
  • Pancreatic Extract (PH: BP 2010)
  • Pancreatin (PH: BP 2010, USP 32, JP VIII)
  • Pancreatis pulvis (PH: Ph. Eur. 5)
  • Pankreas-Pulver (PH: Ph. Eur. 5)

Brand Names

  • Combizym
    Medinova, Switzerland; Medinova, Thailand; Sankyo, Bahrain; Sankyo, Poland; Sankyo, Taiwan; Will, Luxembourg


  • Cotazym
    UCB, Germany


  • Creon
    Altana, Argentina; Boehringer Ingelheim, New Zealand; Dr. Fisher, Netherlands; EU-Pharma, Netherlands; Euro, Netherlands; Italmex, Mexico; Medcor, Netherlands; Solvay, Australia; Solvay, Belgium; Solvay, Brazil; Solvay, Canada; Solvay, China; Solvay, Finland; Solvay, United Kingdom; Solvay, Greece; Solvay, Hong Kong; Solvay, Ireland; Solvay, Israel; Solvay, Iceland; Solvay, Luxembourg; Solvay, Malaysia; Solvay, Netherlands; Solvay, Norway; Solvay, Peru; Solvay, Philippines; Solvay, Sweden; Solvay, Singapore; Solvay, South Africa; Solvay Pharma, Switzerland


  • Créon
    Solvay, France; Solvay, Tunisia


  • Crezyme
    Opsonin, Bangladesh


  • Digestase
    Bristol-Myers Squibb, Peru


  • Dispeptal
    Nicholas, India


  • Enzym Lefax
    Bayer, Germany


  • Enzym Lefax (Pancreatin and Simeticone)
    Bayer, Germany


  • Eurobiol
    Mayoly-Spindler, France


  • Festal N
    Sanayi ve Ticaret, Bulgaria; Sanofi-Aventis, Turkey


  • Festal
    Aventis, India; Hoechst, Ethiopia; Jugoremedija, Serbia; Sanofi-Aventis, Bangladesh; Sanofi-Aventis, Georgia; Sanofi-Aventis, Venezuela


  • Flazymec (Pancreatin and Simeticone)
    Ifars, Indonesia


  • Gastrix
    Abbott, Czech Republic


  • Helopan
    Nordix, Germany; Nordmark, Germany


  • Helopanflat
    Rösch & Handel, Austria


  • Helopanzym
    Rösch & Handel, Austria


  • Hevert-Enzym comp. (Pancreatin and Dimeticone)
    Hevert, Germany


  • Intestinol
    Koçak, Turkey; Rösch & Handel, Austria


  • Kreon
    Dr. F. Frik, Turkey; Solvay, Austria; Solvay, Bulgaria; Solvay, Czech Republic; Solvay, Germany; Solvay, Estonia; Solvay, Spain; Solvay, Georgia; Solvay, Croatia (Hrvatska); Solvay, Hungary; Solvay, Lithuania; Solvay, Latvia; Solvay, Poland; Solvay, Portugal; Solvay, Russian Federation; Solvay, Slovenia; Solvay, Slovakia


  • Kreon für Kinder (pediatric)
    Solvay, Germany


  • Lipancrea
    Polfa Warszawa, Poland


  • Lipazym
    Bittermedizin, Germany


  • Lypex (veterinary use)
    Vet Plus, United Kingdom


  • Mezym
    Berlin-Chemie, Germany; Berlin-Chemie, Estonia; Berlin-Chemie, Georgia; Berlin-Chemie, Hungary; Berlin-Chemie, Latvia; Berlin-Chemie, Romania; Berlin-Chemie, Russian Federation


  • Neo-Pancreatinum
    Jelfa, Poland


  • Neo-Panpur
    Egis, Hungary


  • Nutrizym
    Merck, Ireland; Merck Serono, United Kingdom


  • Orozim
    Arex Technology Inc., Venezuela


  • Ozym
    Trommsdorff, Germany


  • Panaze
    Krka, Bosnia & Herzegowina; Krka, Slovenia


  • Pancrease
    EU-Pharma, Netherlands; Janssen, Brazil; Janssen, Ireland; Janssen, Netherlands; Janssen-Cilag, United Kingdom


  • Pancreatina II MK
    MK, Colombia


  • Pancreatine (veterinary use)
    MP Labo, France


  • Pancreolan
    Leciva, Czech Republic; Zentiva, Slovakia


  • Pancrestal
    Gaco, Bangladesh


  • Pancrex V
    Paines & Byrne, United Kingdom


  • Pancrex
    Paines & Byrne, United Kingdom; Paines & Byrne, New Zealand; United Drug, Ireland


  • Pancrex (veterinary use)
    Pfizer Animal Health, Belgium; Pfizer GmbH Tiergesundheit, Germany; Pharmacia Animal Health, United Kingdom


  • Pancrin (Pancreatin and Dimeticone)
    Solvay, Austria


  • Pangrol
    Berlin-Chemie, Czech Republic; Berlin-Chemie, Germany; Berlin-Chemie, Estonia; Berlin-Chemie, Hungary; Berlin-Chemie, Latvia; Berlin-Chemie, Poland; Berlin-Chemie, Slovakia; Nordmark, Germany


  • Pankreatan
    Grünenthal, Germany; Nordix, Germany; Nordmark, Germany


  • Pankreatin Laves
    Laves, Germany; Nordmark, Germany


  • Pankreatin Mikro-ratiopharm
    Nordmark, Germany; Ratiopharm, Germany


  • Pankreatin Stada
    Stada, Germany


  • Pankreatin
    Galenika, Georgia; Galenika, Serbia; Krka, Slovenia


  • Pankreoflat
    Dr. F. Frik, Turkey; Solvay, Estonia; Solvay, Georgia; Solvay, Israel; Solvay, India


  • Pankreoflat (Pancreatin and Dimeticone)
    Faes, Spain; Solvay, Austria; Solvay, Germany; Solvay, Croatia (Hrvatska); Solvay, South Africa


  • Pankreon
    Zuoz, Venezuela


  • Pankreozym
    Raffo, Argentina


  • Panpur
    Axcan, Germany


  • Panzym (veterinary use)
    Vet Plus, United Kingdom


  • Panzynorm
    Axcan, Germany; German Remedies, India; Krka, Czech Republic; Krka, Estonia; Krka, Georgia; Krka, Russian Federation; Medicopharm, Austria


  • Panzytrat
    Abbott, Estonia; Abbott, Latvia; Axcan, Czech Republic; Axcan, Germany; Axcan, Hungary; Axcan, Lithuania; Axcan, Netherlands; Axcan, Poland; Axcan, Slovakia; Delphi, Netherlands; Dr. Fisher, Netherlands; EU-Pharma, Netherlands; Eureco, Netherlands; Euro, Netherlands; Nordmark, Luxembourg; Sigma-Tau, Switzerland; Technipro, Australia; Vianex / BIANEΞ, Greece


  • Papine
    Duphar, Spain


  • Penzital
    Shreya, Russian Federation


  • Primperan Compositum (Pancreatin and Metoclopramide)
    Delagrange, Indonesia; Soho, Indonesia


  • Suzyme
    Square, Bangladesh


  • Trepetan
    Alpharma, Mexico


  • Tripanzym (Pancreatin and Simeticone)
    Sanbe, Indonesia


  • Tryplase (veterinary use)
    Intervet, France; Intervet, United Kingdom; Intervet, Italy; Intervet, Netherlands


  • Unexym
    Repha, Germany


  • Zymet
    Beximco, Bangladesh

International Drug Name Search

Glossary

BANBritish Approved Name
OSOfficial Synonym
PHPharmacopoeia Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Balminil DM




In the US, Balminil DM is a member of the drug class antitussives and is used to treat Cough.

Ingredient matches for Balminil DM



Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Balminil DM in the following countries:


  • Canada

International Drug Name Search

Saturday, 17 September 2011

Naprosyn CR




Naprosyn CR may be available in the countries listed below.


Ingredient matches for Naprosyn CR



Naproxen

Naproxen is reported as an ingredient of Naprosyn CR in the following countries:


  • Turkey

International Drug Name Search

Monday, 12 September 2011

Fenilbutazone




Fenilbutazone may be available in the countries listed below.


Ingredient matches for Fenilbutazone



Phenylbutazone

Fenilbutazone (DCIT) is known as Phenylbutazone in the US.

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 1 September 2011

Erythromycin Ethylsuccinate




Ingredient matches for Erythromycin Ethylsuccinate



Erythromycin

Erythromycin ethylsuccinate (a derivative of Erythromycin) is reported as an ingredient of Erythromycin Ethylsuccinate in the following countries:


  • United States

International Drug Name Search

Asmafilin




Asmafilin may be available in the countries listed below.


Ingredient matches for Asmafilin



Aminophylline

Aminophylline is reported as an ingredient of Asmafilin in the following countries:


  • Turkey

International Drug Name Search

Friday, 26 August 2011

Warix




Warix may be available in the countries listed below.


Ingredient matches for Warix



Podophyllotoxin

Podophyllotoxin is reported as an ingredient of Warix in the following countries:


  • Switzerland

International Drug Name Search

Monday, 22 August 2011

Bicalutamide CristerS




Bicalutamide CristerS may be available in the countries listed below.


Ingredient matches for Bicalutamide CristerS



Bicalutamide

Bicalutamide is reported as an ingredient of Bicalutamide CristerS in the following countries:


  • France

International Drug Name Search

Sorbitol-Mannitol




Ingredient matches for Sorbitol-Mannitol



Mannitol

Mannitol is reported as an ingredient of Sorbitol-Mannitol in the following countries:


  • United States

Sorbitol

Sorbitol is reported as an ingredient of Sorbitol-Mannitol in the following countries:


  • United States

International Drug Name Search

Thursday, 18 August 2011

Ataraxone




Ataraxone may be available in the countries listed below.


Ingredient matches for Ataraxone



Hydroxyzine

Hydroxyzine hydrochloride (a derivative of Hydroxyzine) is reported as an ingredient of Ataraxone in the following countries:


  • Argentina

International Drug Name Search

Saturday, 13 August 2011

Raycept




Raycept may be available in the countries listed below.


Ingredient matches for Raycept



Calcium Levofolinate

Calcium Levofolinate is reported as an ingredient of Raycept in the following countries:


  • Portugal

International Drug Name Search

Monday, 8 August 2011

Chiggerex




In the US, Chiggerex (benzocaine topical) is a member of the drug class topical anesthetics.

US matches:

  • Chiggerex

Ingredient matches for Chiggerex



Benzocaine

Benzocaine is reported as an ingredient of Chiggerex in the following countries:


  • United States

International Drug Name Search

Thursday, 4 August 2011

Orlaam


Generic Name: levomethadyl (Oral route)

lee-voe-METH-a-dil

Commonly used brand name(s):


In the U.S.


  • Orlaam

Available Dosage Forms:


  • Solution

Therapeutic Class: Analgesic


Chemical Class: Opioid


Uses For Orlaam

Levomethadyl belongs to the group of medicines known as narcotic analgesics. It is used as a substitute for illegal narcotics in addiction treatment programs. This medicine is not a cure for addiction. It is used as part of an overall program that may include counseling, attending support group meetings, and other treatment recommended by your doctor.


Levomethadyl helps prevent the withdrawal symptoms that may occur when an addict stops using other narcotics. In detoxification programs, the amount of levomethadyl used is slowly decreased until an addict becomes drug-free. In maintenance programs, it is used on a long-term basis to help narcotic addicts stay away from street drugs. With long-term use, levomethadyl may decrease an addict's craving for other narcotics.


Another narcotic, methadone, is also used in detoxification and maintenance programs. Methadone begins to work faster than levomethadyl does when treatment is started, but it has to be taken every day. Levomethadyl starts to work slowly, but it does not have to be taken every day. Therefore, some people may start treatment with methadone and then change over to levomethadyl after several weeks. Other people may receive only one medicine or the other during the entire time of treatment. Your doctor and your counselor at the clinic will decide on the best treatment plan for you.


In the U.S., levomethadyl was available only in government-approved treatment clinics.


The manufacturer discontinued ORLAAM® (levomethadyl) in the United States in September 2003.


Before Using Orlaam


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


In the U.S., the law does not allow levomethadyl to be used for treating addicts younger than 18 years of age.


Geriatric


Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. There is no specific information comparing use of levomethadyl in the elderly with use in other age groups.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Acecainide

  • Ajmaline

  • Amiodarone

  • Amisulpride

  • Amitriptyline

  • Amoxapine

  • Aprindine

  • Astemizole

  • Azimilide

  • Bepridil

  • Bretylium

  • Brofaromine

  • Chloral Hydrate

  • Chloroquine

  • Chlorpromazine

  • Cisapride

  • Citalopram

  • Clarithromycin

  • Clorgyline

  • Desipramine

  • Dibenzepin

  • Disopyramide

  • Dofetilide

  • Dolasetron

  • Doxepin

  • Droperidol

  • Ebastine

  • Encainide

  • Erythromycin

  • Flecainide

  • Fluconazole

  • Flucytosine

  • Fluoxetine

  • Fluvoxamine

  • Foscarnet

  • Furazolidone

  • Halofantrine

  • Haloperidol

  • Hydroquinidine

  • Ibutilide

  • Imipramine

  • Iproniazid

  • Isocarboxazid

  • Isradipine

  • Itraconazole

  • Lazabemide

  • Lidoflazine

  • Linezolid

  • Lorcainide

  • Mefloquine

  • Mesoridazine

  • Methdilazine

  • Mexiletine

  • Mibefradil

  • Moclobemide

  • Nialamide

  • Nicardipine

  • Nortriptyline

  • Octreotide

  • Olanzapine

  • Pargyline

  • Pentamidine

  • Phenelzine

  • Pimozide

  • Pirmenol

  • Prajmaline

  • Primaquine

  • Probucol

  • Procainamide

  • Procarbazine

  • Propafenone

  • Protriptyline

  • Quinidine

  • Rasagiline

  • Risperidone

  • Selegiline

  • Sematilide

  • Sertindole

  • Sertraline

  • Sotalol

  • Spiramycin

  • Sulfamethoxazole

  • Sultopride

  • Tedisamil

  • Terfenadine

  • Thioridazine

  • Tiapride

  • Toloxatone

  • Tranylcypromine

  • Trimeprazine

  • Trimethoprim

  • Trimipramine

  • Vasopressin

  • Zimeldine

  • Ziprasidone

  • Zolmitriptan

  • Zotepine

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Acetazolamide

  • Amiloride

  • Arsenic Trioxide

  • Azosemide

  • Bemetizide

  • Bendroflumethiazide

  • Benzthiazide

  • Bumetanide

  • Canrenoate

  • Castor Oil

  • Chlorthalidone

  • Clopamide

  • Cyclothiazide

  • Docusate

  • Enflurane

  • Ethacrynic Acid

  • Etozolin

  • Fenquizone

  • Furosemide

  • Gemifloxacin

  • Halothane

  • Hydrochlorothiazide

  • Hydroflumethiazide

  • Indapamide

  • Isoflurane

  • Ketoconazole

  • Lactulose

  • Magnesium

  • Mannitol

  • Metolazone

  • Piretanide

  • Polythiazide

  • Prochlorperazine

  • Quinethazone

  • Sorbitol

  • Spironolactone

  • Tapentadol

  • Telithromycin

  • Ticrynafen

  • Torsemide

  • Triamterene

  • Trichlormethiazide

  • Trifluoperazine

  • Urea

  • Xipamide

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Cimetidine

  • Phenobarbital

  • Phenytoin

  • Rifampin

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Asthma, emphysema, or other chronic lung disease, or

  • Brain disease or head injury or

  • Colitis or

  • Crohn's disease or

  • Enlarged prostate or problems with urination or

  • Gallbladder disease or gallstones or

  • Heart disease or

  • High blood pressure—Levomethadyl has side effects that could be dangerous to people with these conditions.

  • Kidney disease or

  • Liver disease or

  • Underactive thyroid—The chance of side effects may be increased.

Proper Use of Orlaam


Most patients are given their dose of levomethadyl at the clinic. You may be able to take some doses of your levomethadyl at home if your health care professional feels you are responsible to do that. Most people will have to go to the clinic 3 times a week.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (oral solution):
    • For treating narcotic addiction:
      • Adults—The first dose of levomethadyl for patients who have not started treatment with methadone is between 20 and 40 milligrams (mg). The first dose for patients who have been receiving methadone will be a little higher than the amount of methadone that was being taken every day, but not more than 120 mg. Your doctor will then adjust your dose, depending on whether you experience withdrawal symptoms or side effects after the first dose. More than one change in the dose may be needed, until the right dose for you has been found. Most people will receive levomethadyl 3 times a week, either on Monday, Wednesday, and Friday or on Tuesday, Thursday, and Saturday. Some people need a larger dose on Friday or Saturday, so that the medicine will last until the next visit. In detoxification programs, the dose of levomethadyl will gradually be decreased until the patient is able to stop taking it. In maintenance programs, treatment may be continued as long as needed. If you miss one treatment in your program, your health care professional will have to adjust your treatment schedule and dose; you may need to start a new program with a lower starting dose if you miss more than one treatment or have been off the treatment for more than one week.

      • Children—In the U.S., levomethadyl cannot be used for patients younger than 18 years of age.



Precautions While Using Orlaam


Taking levomethadyl is only part of your treatment. Your doctor and your counselor at the clinic will make a treatment plan for you to follow. This plan may include seeing your counselor at the clinic regularly, attending support group meetings, and making changes in your lifestyle that will help you stay away from illegal drugs. The success of your treatment will depend on how carefully you follow your treatment plan.


This medicine will add to the effects of alcohol and other CNS depressants (medicines that slow down the nervous system, possibly causing drowsiness). Some examples of CNS depressants are antihistamines or medicine for hay fever, other allergies, or colds; sedatives, tranquilizers, or sleeping medicine; prescription pain medicine or other narcotics; barbiturates; medicine for seizures; muscle relaxants; or anesthetics, including some dental anesthetics. It is very important that you do not drink alcoholic beverages or take any CNS depressants during levomethadyl treatment unless you have been directed to do so by a doctor who knows that you are taking levomethadyl. Even if you continue to have some withdrawal symptoms and to crave narcotics for a while after levomethadyl treatment has been started, do not use illegal narcotics or other CNS depressant ``street'' drugs. Taking ``street'' drugs together with levomethadyl has caused some people to die from an overdose.


Levomethadyl may cause some people to become drowsy, especially when treatment is started or the dose is increased. Make sure you know how you react to this medicine before you drive, use machines, or do anything else that could be dangerous if you are drowsy or are not alert and clearheaded. This effect usually goes away after a few days, when your body gets used to the medicine. However, tell your counselor at your next visit to the clinic if any dose causes drowsiness that is severe enough to interfere with your activities.


Dizziness, lightheadedness, or even fainting may occur when you get up suddenly from a lying or sitting position. Getting up slowly may help lessen this problem. Also, lying down for a while may relieve dizziness or lightheadedness.


Tell all health care professionals you go to that you are taking levomethadyl. This is especially important if any kind of surgery or emergency treatment is needed. Serious side effects can occur if your health care professional gives you certain other medicines without knowing that you are taking levomethadyl.


Using narcotics such as levomethadyl for a long time can cause severe constipation. To prevent this, your counselor may direct you to take laxatives, drink a lot of fluids, or increase the amount of fiber in your diet. Be sure to follow the directions carefully, because continuing constipation can lead to more serious problems.


Levomethadyl may cause dryness of the mouth. For temporary relief, use sugarless candy or gum, melt bits of ice in your mouth, or use a saliva substitute. However, if dry mouth continues for more than 2 weeks, check with your dentist. Continuing dryness of the mouth may increase the chance of dental disease, including tooth decay, gum disease, and fungus infections.


For women only:


  • Although there may be rare exceptions, levomethadyl is not recommended for use by pregnant women. Pregnancy tests will be given once a month during treatment. If you miss any of these tests you may not be able to continue receiving levomethadyl.

  • Women who may become pregnant should use effective birth control during levomethadyl treatment. If you are not sure what method of birth control will work best for you, check with your counselor at the clinic.

  • If you plan to become pregnant, you should first discuss your plans with your doctor or your counselor. They can arrange for you to receive methadone instead of levomethadyl.

  • If you think you have become pregnant during treatment, tell your counselor right away.

Some people may be transferred to methadone after receiving levomethadyl for a while. If you are given any take-home doses of methadone, do not take the first dose of methadone for at least 48 hours (2 days) after your last dose of levomethadyl. Taking the 2 medicines too close together may cause an overdose.


If you think you may have taken an overdose of narcotics, get emergency help right away. Taking an overdose of narcotics, or taking alcohol or CNS depressants with narcotics, may lead to unconsciousness or death. Signs of overdose include convulsions (seizures); confusion; severe dizziness, drowsiness, nervousness, restlessness, or weakness; and very slow or troubled breathing. It is very important that the emergency room doctor knows that you are physically dependent on a narcotic called levomethadyl, that using naloxone to treat your overdose is very likely to cause withdrawal symptoms, and that you will need to be watched for a long time because levomethadyl's effects last for several days. However, you may not be able to give this information to the doctor yourself. Therefore, you should direct friends and family members to give this information to the doctor, if necessary.


Orlaam Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


Signs and symptoms of overdose
  • Cold, clammy skin

  • confusion

  • convulsions (seizures)

  • dizziness (severe)

  • drowsiness (severe)

  • low blood pressure

  • nervousness or restlessness (severe)

  • pinpoint pupils of eyes

  • slow heartbeat

  • slow or troubled breathing

  • weakness (severe)

Check with your doctor as soon as possible if any of the following side effects occur:


Less common
  • Mental depression

  • skin rash

  • swelling of face, fingers, feet, and/or lower legs

  • weight gain

After you stop using this medicine, it may still produce some side effects that need attention. During this period of time, check with your doctor immediately if you notice the following side effects:


Signs of too much levomethadyl
  • Drowsiness (severe)

  • feeling ``wired''

Signs of not enough levomethadyl (withdrawal symptoms)
  • Body aches, diarrhea

  • fast heartbeat

  • gooseflesh

  • increased sweating

  • loss of appetite

  • nausea or vomiting

  • nervousness, restlessness, or irritability

  • runny nose

  • shivering or trembling

  • sneezing

  • stomach cramps

  • trouble in sleeping

  • unexplained fever

  • unusually large pupils of eyes

  • weakness

  • yawning

The withdrawal side effects listed above may also occur after levomethadyl treatment has been stopped or during a changeover from levomethadyl to methadone. Always check with your counselor at the clinic if withdrawal side effects occur after you stop taking levomethadyl.


Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Abdominal or stomach pain

  • constipation

  • general feeling of discomfort or illness

  • joint pain

  • sexual problems in males

Less common or rare
  • Anxiety

  • back pain

  • blurred vision

  • chills

  • coughing

  • decreased desire for sex

  • dizziness, lightheadedness, or feeling faint when rising from a lying or sitting position

  • drowsiness

  • dry mouth

  • false sense of well-being

  • flu-like symptoms

  • headache

  • hot flashes

  • muscle pain

  • unusual dreams

  • watery eyes

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.



The information contained in the Thomson Healthcare (Micromedex) products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Healthcare does not assume any responsibility or risk for your use of the Thomson Healthcare products.


More Orlaam resources


  • Orlaam Drug Interactions
  • Orlaam Support Group
  • 0 Reviews · Be the first to review/rate this drug

Thursday, 21 July 2011

Indager




Indager may be available in the countries listed below.


Ingredient matches for Indager



Meloxicam

Meloxicam is reported as an ingredient of Indager in the following countries:


  • Mexico

International Drug Name Search

Monday, 18 July 2011

Alprazolam Germed




Alprazolam Germed may be available in the countries listed below.


Ingredient matches for Alprazolam Germed



Alprazolam

Alprazolam is reported as an ingredient of Alprazolam Germed in the following countries:


  • Italy

International Drug Name Search

Wednesday, 13 July 2011

Azithromycin AL




Azithromycin AL may be available in the countries listed below.


Ingredient matches for Azithromycin AL



Azithromycin

Azithromycin monohydrate (a derivative of Azithromycin) is reported as an ingredient of Azithromycin AL in the following countries:


  • Germany

International Drug Name Search

Wednesday, 6 July 2011

Etiplus




Etiplus may be available in the countries listed below.


Ingredient matches for Etiplus



Etidronic Acid

Etidronic Acid disodium salt (a derivative of Etidronic Acid) is reported as an ingredient of Etiplus in the following countries:


  • Greece

International Drug Name Search

Sunday, 3 July 2011

Sanicon




Sanicon may be available in the countries listed below.


Ingredient matches for Sanicon



Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Sanicon in the following countries:


  • Taiwan

International Drug Name Search

Saturday, 2 July 2011

Orhto 777-28




Orhto 777-28 may be available in the countries listed below.


Ingredient matches for Orhto 777-28



Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Orhto 777-28 in the following countries:


  • Japan

Norethisterone

Norethisterone is reported as an ingredient of Orhto 777-28 in the following countries:


  • Japan

International Drug Name Search

Thursday, 30 June 2011

Flumates




Flumates may be available in the countries listed below.


Ingredient matches for Flumates



Beclometasone

Beclometasone 17α,21-dipropionate (a derivative of Beclometasone) is reported as an ingredient of Flumates in the following countries:


  • Chile

International Drug Name Search

Saturday, 18 June 2011

Penicilina Procainica




Penicilina Procainica may be available in the countries listed below.


Ingredient matches for Penicilina Procainica



Benzylpenicillin

Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of Penicilina Procainica in the following countries:


  • Peru

International Drug Name Search

Friday, 17 June 2011

Klaz




Klaz may be available in the countries listed below.


Ingredient matches for Klaz



Clarithromycin

Clarithromycin is reported as an ingredient of Klaz in the following countries:


  • Philippines

International Drug Name Search

Wednesday, 15 June 2011

Dermabet




Ingredient matches for Dermabet



Betamethasone

Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Dermabet in the following countries:


  • United States

International Drug Name Search

Sunday, 12 June 2011

Pipraks




Pipraks may be available in the countries listed below.


Ingredient matches for Pipraks



Piperacillin

Piperacillin sodium salt (a derivative of Piperacillin) is reported as an ingredient of Pipraks in the following countries:


  • Turkey

  • Yemen

International Drug Name Search

Saturday, 11 June 2011

Ergix expectorant sans sucre




Ergix expectorant sans sucre may be available in the countries listed below.


Ingredient matches for Ergix expectorant sans sucre



Carbocisteine

Carbocisteine is reported as an ingredient of Ergix expectorant sans sucre in the following countries:


  • France

International Drug Name Search

Wednesday, 8 June 2011

Klozapin Sandoz




Klozapin Sandoz may be available in the countries listed below.


Ingredient matches for Klozapin Sandoz



Clozapine

Clozapine is reported as an ingredient of Klozapin Sandoz in the following countries:


  • Slovakia

International Drug Name Search

Monday, 6 June 2011

Anti-Bit Sampuan




Anti-Bit Sampuan may be available in the countries listed below.


Ingredient matches for Anti-Bit Sampuan



Phenothrin

Phenothrin is reported as an ingredient of Anti-Bit Sampuan in the following countries:


  • Turkey

International Drug Name Search

Wednesday, 1 June 2011

Simratio




Simratio may be available in the countries listed below.


Ingredient matches for Simratio



Simvastatin

Simvastatin is reported as an ingredient of Simratio in the following countries:


  • Poland

International Drug Name Search

dexamethasone Intraocular



dex-a-METH-a-sone


Commonly used brand name(s)

In the U.S.


  • Ozurdex

Available Dosage Forms:


  • Implant

Pharmacologic Class: Adrenal Glucocorticoid


Uses For dexamethasone


Dexamethasone intravitreal implant is used to treat an eye disease called macular edema (swelling of the back of the eye). Macular edema occurs when a blood vessel in the eye is clogged. This causes vision changes that must be treated right away. Dexamethasone is a corticosteroid (steroid medicine) that helps reduce the swelling in the eye.


Dexamethasone intravitreal implant is also used to treat an eye disease called uveitis (swelling in the middle part of the eye).


dexamethasone is available only with your doctor's prescription.


Before Using dexamethasone


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For dexamethasone, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to dexamethasone or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of dexamethasone implant in the pediatric population. Safety and efficacy have not been established.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of dexamethasone implant in the elderly.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving dexamethasone, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using dexamethasone with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Praziquantel

  • Rilpivirine

  • Rotavirus Vaccine, Live

Using dexamethasone with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Aldesleukin

  • Boceprevir

  • Bupropion

  • Darunavir

  • Dasatinib

  • Efavirenz

  • Etravirine

  • Fosamprenavir

  • Imatinib

  • Ixabepilone

  • Lapatinib

  • Nevirapine

  • Nilotinib

  • Quetiapine

  • Rivaroxaban

  • Romidepsin

  • Sunitinib

  • Telaprevir

  • Temsirolimus

  • Thalidomide

  • Ticagrelor

  • Vandetanib

Using dexamethasone with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Alatrofloxacin

  • Alcuronium

  • Aminoglutethimide

  • Aprepitant

  • Aspirin

  • Atracurium

  • Balofloxacin

  • Caspofungin

  • Cinoxacin

  • Ciprofloxacin

  • Clinafloxacin

  • Enoxacin

  • Fleroxacin

  • Fluindione

  • Flumequine

  • Fosaprepitant

  • Fosphenytoin

  • Gallamine

  • Gemifloxacin

  • Grepafloxacin

  • Hexafluorenium

  • Itraconazole

  • Levofloxacin

  • Licorice

  • Lomefloxacin

  • Metocurine

  • Moxifloxacin

  • Norfloxacin

  • Ofloxacin

  • Pancuronium

  • Pefloxacin

  • Phenobarbital

  • Phenytoin

  • Primidone

  • Prulifloxacin

  • Rifampin

  • Rifapentine

  • Ritonavir

  • Rosoxacin

  • Rufloxacin

  • Saiboku-To

  • Sparfloxacin

  • Temafloxacin

  • Tosufloxacin

  • Trovafloxacin Mesylate

  • Vecuronium

  • Warfarin

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of dexamethasone. Make sure you tell your doctor if you have any other medical problems, especially:


  • Detached retina (eye disorder) or

  • Endophthalmitis (inflammation of the eye) or

  • Glaucoma (increased pressure in the eye) or

  • Herpes infection of the eye, history of—Use with caution. May make these conditions worse.

  • Eye infection caused by a virus, fungus, or bacteria or

  • Glaucoma, advanced—Should not be used in patients with these conditions.

Proper Use of dexamethasone


dexamethasone is an implant that is placed in your eye. It will stay in your eye and does not need to be removed. An eye doctor will give you dexamethasone in a hospital or clinic setting.


Precautions While Using dexamethasone


Your eye doctor will want to check your progress at regular visits, especially during the first few weeks after you receive dexamethasone.


Serious eye problems may occur after receiving dexamethasone. Check with your eye doctor right away if you have a change in vision or the eye becomes red, sensitive to light, or painful. Also, tell your doctor if you feel increased pressure in the eye.


dexamethasone may cause temporary blurred vision. Avoid driving, using machines, or doing anything else that could be dangerous if you are not able to see well.


dexamethasone Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor or nurse immediately if any of the following side effects occur:


More common
  • Bloody eye

  • blurred vision

  • change in vision

  • eye pain

  • loss of vision

  • redness of the eye

  • redness of the white part of the eye or inside of the eyelid

Less common
  • Blindness

  • decreased vision

  • gradual loss of vision

  • headache

  • nausea

  • seeing a veil or curtain across part of your vision

  • seeing flashes or sparks of light

  • seeing floating spots before the eyes

  • vomiting

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More dexamethasone Intraocular resources


  • Dexamethasone Intraocular Use in Pregnancy & Breastfeeding
  • Dexamethasone Intraocular Drug Interactions
  • Dexamethasone Intraocular Support Group
  • 0 Reviews for Dexamethasone Intraocular - Add your own review/rating


Compare dexamethasone Intraocular with other medications


  • Acute Otitis Externa
  • Conjunctivitis
  • Cyclitis
  • Iritis
  • Keratitis
  • Macular Edema
  • Uveitis
  • Uveitis, Posterior

Saturday, 28 May 2011

Pravastatina Merck




Pravastatina Merck may be available in the countries listed below.


Ingredient matches for Pravastatina Merck



Pravastatin

Pravastatin is reported as an ingredient of Pravastatina Merck in the following countries:


  • Spain

International Drug Name Search

Wednesday, 25 May 2011

Cotrimoxazol Genericon




Cotrimoxazol Genericon may be available in the countries listed below.


Ingredient matches for Cotrimoxazol Genericon



Sulfamethoxazole

Sulfamethoxazole is reported as an ingredient of Cotrimoxazol Genericon in the following countries:


  • Austria

Trimethoprim

Trimethoprim is reported as an ingredient of Cotrimoxazol Genericon in the following countries:


  • Austria

International Drug Name Search

Saturday, 21 May 2011

Finasterida Tevagen




Finasterida Tevagen may be available in the countries listed below.


Ingredient matches for Finasterida Tevagen



Finasteride

Finasteride is reported as an ingredient of Finasterida Tevagen in the following countries:


  • Spain

International Drug Name Search

Wednesday, 11 May 2011

Progate




Progate may be available in the countries listed below.


Ingredient matches for Progate



Dipivefrine

Dipivefrine hydrochloride (a derivative of Dipivefrine) is reported as an ingredient of Progate in the following countries:


  • Japan

International Drug Name Search

Saturday, 7 May 2011

Anasec




Anasec may be available in the countries listed below.


Ingredient matches for Anasec



Omeprazole

Omeprazole is reported as an ingredient of Anasec in the following countries:


  • Bangladesh

International Drug Name Search

Thursday, 5 May 2011

Clomipramine (chlorhydrate) Mylan




Clomipramine (chlorhydrate) Mylan may be available in the countries listed below.


Ingredient matches for Clomipramine (chlorhydrate) Mylan



Clomipramine

Clomipramine hydrochloride (a derivative of Clomipramine) is reported as an ingredient of Clomipramine (chlorhydrate) Mylan in the following countries:


  • France

International Drug Name Search

Sunday, 1 May 2011

Fluoxetina Salipax




Fluoxetina Salipax may be available in the countries listed below.


Ingredient matches for Fluoxetina Salipax



Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Fluoxetina Salipax in the following countries:


  • Portugal

International Drug Name Search

Saturday, 23 April 2011

Sertral




Sertral may be available in the countries listed below.


Ingredient matches for Sertral



Sertraline

Sertraline is reported as an ingredient of Sertral in the following countries:


  • Estonia

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Sertral in the following countries:


  • Iceland

  • Latvia

  • Lithuania

  • Malta

International Drug Name Search

Fénofibrate Fournier




Fénofibrate Fournier may be available in the countries listed below.


Ingredient matches for Fénofibrate Fournier



Fenofibrate

Fenofibrate is reported as an ingredient of Fénofibrate Fournier in the following countries:


  • France

International Drug Name Search

Saturday, 16 April 2011

Belcomycine S




Belcomycine S may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Belcomycine S



Colistin Sulfate

Colistin sulfate (a derivative of Colistin) is reported as an ingredient of Belcomycine S in the following countries:


  • France

International Drug Name Search

Saturday, 9 April 2011

Etoposido GP Pharm




Etoposido GP Pharm may be available in the countries listed below.


Ingredient matches for Etoposido GP Pharm



Etoposide

Etoposide is reported as an ingredient of Etoposido GP Pharm in the following countries:


  • Peru

International Drug Name Search

Friday, 8 April 2011

Cestal Cat




Cestal Cat may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Cestal Cat



Praziquantel

Praziquantel is reported as an ingredient of Cestal Cat in the following countries:


  • Poland

Pyrantel

Pyrantel embonate (a derivative of Pyrantel) is reported as an ingredient of Cestal Cat in the following countries:


  • Poland

International Drug Name Search

Tuesday, 15 March 2011

Microval




Microval may be available in the countries listed below.


Ingredient matches for Microval



Levonorgestrel

Levonorgestrel is reported as an ingredient of Microval in the following countries:


  • Chile

  • France

  • Luxembourg

  • South Africa

  • Tunisia

  • Venezuela

International Drug Name Search

Monday, 7 March 2011

Molsidomine Arrow




Molsidomine Arrow may be available in the countries listed below.


Ingredient matches for Molsidomine Arrow



Molsidomine

Molsidomine is reported as an ingredient of Molsidomine Arrow in the following countries:


  • France

International Drug Name Search

Sunday, 6 March 2011

Andox




Andox may be available in the countries listed below.


Ingredient matches for Andox



Paracetamol

Paracetamol is reported as an ingredient of Andox in the following countries:


  • Mexico

International Drug Name Search

Thursday, 24 February 2011

Batroxobin




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

B02BX03

CAS registry number (Chemical Abstracts Service)

0009039-61-6

Therapeutic Category

Hemostatic agent

Chemical Name

Proteinase, Bothrops atrox serine

Foreign Names

  • Batroxobinum (Latin)
  • Batroxobin (German)
  • Batroxobine (French)
  • Batroxobina (Spanish)

Generic Names

  • Batroxobin (OS: JAN)
  • Batroxobina (OS: DCIT)
  • Batroxobine (OS: DCF)
  • Reptilase (IS)

Brand Names

  • Defibrase
    Tobishi, Japan


  • Reptilase
    Tobishi, Japan

International Drug Name Search

Glossary

DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 22 February 2011

Dexaphos




Dexaphos may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Dexaphos



Dexamethasone

Dexamethasone 21-(disodium phosphate) (a derivative of Dexamethasone) is reported as an ingredient of Dexaphos in the following countries:


  • Australia

International Drug Name Search

Sunday, 20 February 2011

Térazosine Merck




Térazosine Merck may be available in the countries listed below.


Ingredient matches for Térazosine Merck



Terazosin

Terazosin hydrochloride (a derivative of Terazosin) is reported as an ingredient of Térazosine Merck in the following countries:


  • France

International Drug Name Search

Saturday, 19 February 2011

Oprad




Oprad may be available in the countries listed below.


Ingredient matches for Oprad



Amikacin

Amikacin sulfate (a derivative of Amikacin) is reported as an ingredient of Oprad in the following countries:


  • Mexico

International Drug Name Search

Thursday, 17 February 2011

Imda




Imda may be available in the countries listed below.


Ingredient matches for Imda



Bicalutamide

Bicalutamide is reported as an ingredient of Imda in the following countries:


  • Argentina

International Drug Name Search

Saturday, 12 February 2011

Orbeseal




Orbeseal may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Orbeseal



Bismuth Subnitrate

Bismuth Subnitrate is reported as an ingredient of Orbeseal in the following countries:


  • Austria

  • Belgium

  • Finland

  • France

  • Germany

  • Italy

  • Netherlands

  • Norway

  • Switzerland

International Drug Name Search

Wednesday, 9 February 2011

Pradaxa


Pradaxa is a brand name of dabigatran, approved by the FDA in the following formulation(s):


PRADAXA (dabigatran etexilate mesylate - capsule; oral)



  • Manufacturer: BOEHRINGER INGELHEIM

    Approval date: October 18, 2010

    Strength(s): 150MG [RLD], 75MG

Has a generic version of Pradaxa been approved?


No. There is currently no therapeutically equivalent version of Pradaxa available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Pradaxa. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions
    Patent 6,087,380
    Issued: July 11, 2000
    Inventor(s): Hauel; Norbert & Priepke; Henning & Ries; Uwe & Stassen; Jean Marie & Wienen; Wolfgang
    Assignee(s): Boehringer Ingelheim Pharma KG
    New disubstituted bicyclic heterocycles of general formula EQU R.sub.a --A--Het--B--Ar--E (I) Compounds of the above general formula I, wherein E denotes an R.sub.b NH--C(.dbd.NH)-- group, have valuable pharmacological properties, particularly a thrombin-inhibiting effect and the effect of prolonging thrombin time, and those wherein E denotes a cyano group, are valuable intermediates for preparing the other compounds of general formula I. Exemplary compounds of formula I are: (a) 1-Methyl-2-[N-(4-amidinophenyl)-aminomethyl]-benzimidazol-5-yl-carboxylic acid-N-phenyl-N-(2-hydroxycarbonylethyl)-amide, (b) 1-Methyl-2-[N-(4-amidinophenyl)-aminomethyl]-benzimidazol-5-yl-carboxylic acid-N-(2-pyridyl)-N-(hydroxycarbonylmethyl)-amide, (c) 1-Methyl-2-[N-(4-amidino-2-methoxy-phenyl)-aminomethyl]-benzimidazol-5-yl- carboxylic acid-N-(2-pyridyl)-N-(hydroxycarbonylmethyl)-amide, and (d) 1-Methyl-2-[N-[4-(N-n-hexyloxycarbonylamidino)phenyl]aminomethyl]-benzimid azol-5-yl-carboxylic acid-N-(2-pyridyl)-N-(2-ethoxycarbonylethyl) amide.
    Patent expiration dates:

    • February 18, 2018
      ✓ 
      Patent use: INHIBITION OF THROMBIN
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Film container
    Patent 7,866,474
    Issued: January 11, 2011
    Inventor(s): Geser; Johannes & Beyer; Sebastian
    Assignee(s): Boehringer Ingelheim International GmbH
    A film container (FIG. 4) comprises two rectangular films (5) joined together at their periphery to form a receiving chamber (6) for a filling (7), particularly a pharmaceutical formulation of an active substance, at least one of said films (5) being provided, for the purpose of tearing it open, with a marking (13) formed within the connecting region, which is exposed after the films (5) have been bent. The marking (13) extends centrally between two opposing outer edges (11) of the film container (1).
    Patent expiration dates:

    • August 31, 2027
      ✓ 
      Drug product




  • 3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl) phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as a medicament
    Patent 7,932,273
    Issued: April 26, 2011
    Inventor(s): Schmid; Rolf & Sieger; Peter & Sobotta; Rainer
    Assignee(s): Boehringer Ingelheim International GmbH
    Ethyl 3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl)phenylamino]methyl}-1-methyl-1H-benzimidazole-5-carbonyl)pyridin-2-ylamino]propionate methanesulfonate in the crystalline modifications I and II and as the hemihydrate and the use thereof as a pharmaceutical composition.
    Patent expiration dates:

    • September 7, 2025
      ✓ 
      Drug substance
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • October 19, 2015 - NEW CHEMICAL ENTITY

See also...

  • Pradaxa Consumer Information (Drugs.com)
  • Pradaxa Consumer Information (Wolters Kluwer)
  • Pradaxa Consumer Information (Cerner Multum)
  • Pradaxa Advanced Consumer Information (Micromedex)
  • Dabigatran Consumer Information (Wolters Kluwer)
  • Dabigatran Consumer Information (Cerner Multum)
  • Dabigatran Advanced Consumer Information (Micromedex)

Pilocarpine Faure




Pilocarpine Faure may be available in the countries listed below.


Ingredient matches for Pilocarpine Faure



Pilocarpine

Pilocarpine nitrate (a derivative of Pilocarpine) is reported as an ingredient of Pilocarpine Faure in the following countries:


  • Monaco

International Drug Name Search